Hydrogen inhalation ameliorates lipopolysaccharide-induced acute lung injury in mice. 2011

Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
Burn Center, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.

Acute lung injury (ALI) is a serious illness, the incidence and mortality of which are very high. Free radicals, such as hydroxyl radicals (OH) and peroxynitrite (ONOO(-)), are considered to be the final causative molecules in the pathogenesis of ALI. Hydrogen, a new antioxidant, can selectively reduce OH and ONOO(-). In the present study, we investigated the hypothesis that hydrogen inhalation could ameliorate ALI induced by intra-tracheal lipopolysaccharide (LPS, 5mg/kg body weight). Mice were randomized into three groups: sham group (physiological saline+2% hydrogen mixed gas), control group (LPS+normal air) and experiment group (LPS+2% hydrogen mixed gas). Bronchoalveolar lavage fluid (BALF) was performed to determine the total protein concentrations and pro-inflammatory cytokines. Lung tissues were assayed for oxidative stress variables, wet/dry (W/D) ratio, histological, immunohistochemistry and Western blotting examinations. Our experiments exhibited that hydrogen improved the survival rate of mice and induced a decrease in lung W/D ratio. In addition, hydrogen decreased malonaldehyde and nitrotyrosine content, inhibited myeloperoxidase and maintained superoxide dismutase activity in lung tissues and associated with a decrease in the expression of TNF-α, IL-1β, IL-6 and total protein concentrations in the BALF. Hydrogen further attenuated histopathological alterations and mitigated lung cell apoptosis. Importantly, hydrogen inhibited the activation of P-JNK, and also reversed changes in Bax, Bcl-xl and caspase-3. In conclusion, our data demonstrated that hydrogen inhalation ameliorated LPS-induced ALI and it may be exerting its protective role by preventing the activation of ROS-JNK-caspase-3 pathway.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D011654 Pulmonary Edema Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening. Wet Lung,Edema, Pulmonary,Edemas, Pulmonary,Pulmonary Edemas,Lung, Wet,Lungs, Wet,Wet Lungs
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D006859 Hydrogen The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas. Protium,Hydrogen-1
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
December 2014, Inflammation,
Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
January 2010, Critical care (London, England),
Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
January 2015, Inflammation,
Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
May 2012, Shock (Augusta, Ga.),
Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
September 2015, Journal of ethnopharmacology,
Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
January 2022, BioMed research international,
Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
January 2012, The American journal of Chinese medicine,
Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
June 2017, Experimental and therapeutic medicine,
Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
March 2015, European journal of pharmacology,
Xiaochen Qiu, and Hengyu Li, and Hongtai Tang, and Yichao Jin, and Wuquan Li, and YuSun, and PingFeng, and Xuejun Sun, and Zhaofan Xia
June 2011, Toxicology and applied pharmacology,
Copied contents to your clipboard!